Schedule 13G ownership disclosure
VIRIOS THERAPEUTICS INC
Security class unavailable · CUSIP: 92829J104
Event date: 2023-11-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,316,049
- Percent of class
- 6.8400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001654954-23-014307
- Form type
- SC 13G
- Filer
- Corday Brian David
- CIK
- CIK 1322787
- Filed
- Nov 14, 2023
- Reporting period
- Nov 14, 2023
- Description
- Schedule 13G beneficial ownership